| Median Raphe Neurons | |
|---|---|
| Lineage | Neuron > Brainstem > Serotonergic |
| Markers | TPH2, SLC6A4, GAD2, PET1 |
| Brain Regions | Median Raphe Nucleus |
| Disease Vulnerability | Parkinson's Disease, Depression, Alzheimer's Disease |
Median raphe neurons are a population of serotonergic neurons located in the midline of the midbrain and pons. These neurons form the dorsal and median raphe nuclei, which are the primary sources of serotonin (5-HT) in the central nervous system. They play critical roles in mood regulation, sleep-wake cycles, and are prominently affected in neurodegenerative and psychiatric disorders.
Median Raphe Neurons are a specialized cell type classified within the Neuron > Brainstem > Serotonergic.[1] These cells are primarily found in the Median Raphe Nucleus and are characterized by expression of marker genes including TPH2, SLC6A4, GAD2, PET1. They are selectively vulnerable in Parkinson's Disease, Depression, and Alzheimer's Disease.
Median raphe neurons have distinctive morphological and molecular features:
These neurons are identified by the expression of key marker genes:
Median raphe neurons play essential roles in regulating mood, arousal, and cognitive functions:
The median raphe projects to:
Median raphe neurons show selective vulnerability in several neurodegenerative and psychiatric conditions:
In Parkinson's Disease, median raphe neurons exhibit:
The degeneration contributes to:
Median raphe dysfunction is central to Depression:
In Alzheimer's disease, median raphe neurons show:
The study of Median Raphe Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.